Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $43.83 is 15.19% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 44.52||$ 58.79|
|Low:||$ 42.03||$ 38.05|
Company Description (as filed with the SEC)
We are a biopharmaceutical company involved in the development of an injectable collagenase clostridium histolyticum for multiple indications. We currently have a development and license agreement with Endo Global Ventures, a Bermuda unlimited liability company ("Endo Global Ventures"), an affiliate of Endo International plc ("Endo"), for injectable collagenase for marketed indications and indications in development. Endo assumed this agreement when Endo acquired Auxilium Pharmaceuticals, Inc. ("Auxilium") on January 29, 2015 (the "Acquisition"). Injectable collagenase clostridium histolyticum is marketed as XIAFLEX® (or Xiapex® in Europe). On August 31, 2011, we entered into the Second Amended and Restated Development and License Agreement (the "License Agreement") with Auxilium for XIAFLEX. The License Agreement was filed with the Securities and Exchange Commission (the "SEC") on September 1, 2011 as Exhibit 10.1 to a Current Report on Form 8-K. ... More ...
Nasdaq Official Price
Apr. 19, 2018
Apr. 19, 2018